During the past decade, Sharp Rees-Stealy Medical Group conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 12 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sharp Rees-Stealy Medical Group" #1 sponsor was "Pfizer" with 10 trials, followed by "Abbott" with 4 trials sponsored, "Telik" with 3 trials sponsored, "Dendreon" with 2 trials sponsored and "Exact Sciences Corporation" with 2 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sharp Rees-Stealy Medical Group" #1 collaborator was "Astellas Pharma Inc" with 3 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 2 trials as a collaborator, "Cancer International Research Group (CIRG)" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Sharp Rees-Stealy Medical Group" are "Crohn's Disease" (6 trials), "Ulcerative Colitis" (6 trials), "Prostate Cancer" (3 trials), "Chronic Hepatitis" (2 trials) and "Colonic Diseases" (2 trials). Many other conditions were trialed in "Sharp Rees-Stealy Medical Group" in a lesser frequency.

Most popular intervention types in "Sharp Rees-Stealy Medical Group" are "Drug" (31 trials), "Biological" (5 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "CP-690,550" (3 trials), "Adefovir" (2 trials), "Bevacizumab" (2 trials) and "Clevudine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sharp Rees-Stealy Medical Group" are 28 trials for "All" genders, 7 trials for "Male" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Sharp Rees-Stealy Medical Group". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Sharp Rees-Stealy Medical Group, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Sharp Rees-Stealy Medical Group, 2 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".